Arkolith/Insider Trading/ALT/Form 4

Roberts M Scot

Chief Scientific OfficerAltimmune, Inc. (ALT) · full profile →Form 4 · filed Feb 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
7 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2025Option exercise(M)8K—$076K
Feb 2, 2025Tax withholding(F)2K$6.64$15K73K
Feb 1, 2025Option exercise(M)6K—$070K
Feb 1, 2025Tax withholding(F)2K$6.64$12K68K
Jan 31, 2025Grant(A)3K$5.18$16K63K
Jan 30, 2025Option exercise(M)9K—$063K
Jan 30, 2025Tax withholding(F)3K$7.00$19K60K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 2, 2025Option exercise(M)8K—$08K
Feb 1, 2025Option exercise(M)6K—$00
Jan 30, 2025Option exercise(M)9K—$019K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-008770) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML